fig2
Figure 2. B-scan and en face OCT images, H&E-stained sections, and CD31 immunohistochemistry on postoperative days 3, 7, and 11. (A) Timeline of wound assessment in mice receiving Lando artificial dermal scaffolds; (B) Wounds treated with Lando artificial dermal scaffolds and Beifuji (recombinant bovine basic fibroblast growth factor); (C) Wounds treated with Lando artificial dermal scaffolds alone (control group). B-scan: Brightness scan; OCT: optical coherence tomography; H&E: hematoxylin and eosin; CD31: cluster of differentiation 31.





